Return to top of page

Catching Up with Dr. Foluso Fakorede: 2025 Silver Innovator Award Recipient

September 3, 2025   |   Matthew Thompson   |   Healthy Aging, Cardiovascular Disease, Who We Are, Alliance Initiatives

Each year, leading advocates, policymakers, and champions in the aging community gather in Washington, DC, to celebrate our collective efforts to enhance healthy aging. As we approach our annual Heroes in Health Celebration on Tuesday, September 30, 2025, we’re highlighting the remarkable work of our award honorees in this blog series.

Our 2025 Silver Innovator, Dr. Foluso Fakorede, is a trailblazing interventional cardiologist dedicated to reducing health disparities in underserved communities. Specializing in preventive cardiovascular care, women’s heart health, and catheter-based treatments for Coronary and Peripheral Artery Disease (CAD and PAD), Dr. Fakorede has centered his work on expanding access to quality care, beginning in the Mississippi Delta. He has also partnered with Congress to establish the first bipartisan PAD Caucus, advancing legislation to prevent avoidable amputations and improve PAD research, education, and treatment nationwide. 

We caught up with Dr. Fakorede this summer to chat about his work:

Black Americans have the highest prevalence of PAD and neglected risk factors, yet the lowest awareness of the disease. And the problem isn’t limited to one group—overall awareness is low among patients, providers, and communities nationwide. This means people most at risk are often never told they have PAD until it’s too late.

PAD is more than a limb issue—it is a powerful marker of systemic disease that signals elevated risk for heart attacks, strokes, and death. Early detection of PAD is a gateway to upstream management of multiple chronic conditions, reducing not only limb loss but also the cardiovascular events that claim far more lives. Detecting and treating PAD early could also save billions of dollars in healthcare costs currently spent on managing the devastating consequences of this preventable epidemic.

The stakes are high: in the U.S., more than 160,000 amputations occur each year, many of them entirely preventable if PAD is detected and treated early. PAD–CLTI has worse three-year mortality than breast, prostate, or colon cancer, and approaches that of lung cancer—yet unlike cancer, there is no systematic screening and no mandate for pre-amputation vascular evaluation. In hospitals without limb salvage protocols, patients—disproportionately older, Black, Hispanic, or Native American—are often sent straight to amputation without any attempt at revascularization.

Join us on Tuesday, September 30, 2025 at the Waldorf Astoria in Washington, DC as we celebrate “Trust, Empowerment, and Healthy Aging,” at our annual Heroes in Health Celebration. Registration is now open to purchase tickets. To learn more about awards dinner, visit our event page.

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator Four-Star Rating Badge

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.

Living Longer and Loving It

Sign up for our monthly e-mail newsletter for the latest information on
scientific research on aging and health.